Teladoc Health, Inc. (NYSE: TDOC), a prominent player in the virtual care sector, released its financial results for the fourth quarter and full year ending December 31, 2025. The results reveal a picture of relative stability in revenue alongside a significant reduction in net losses, aligning with the company's strategic focus on innovation and operational efficiency.

Key Financial Highlights

Fourth Quarter 2025 Revenue: $642.3 million, unchanged from the previous year.

Full Year 2025 Revenue: $2.53 billion, down 2% year-over-year.

Fourth Quarter Net Loss: $25.1 million, or $0.14 per share, a marked improvement from a net loss of $48.4 million, or $0.28 per share, in the same quarter last year.

Full Year Net Loss: $200.3 million, or $1.14 per share, substantially reduced from a loss of $1 billion, or $5.87 per share, in 2024.

Adjusted EBITDA for Q4 2025: $83.8 million, up 12% year-over-year.

Full Year Adjusted EBITDA: $281.1 million, reflecting a 10% decrease from 2024.

Revenue Breakdown

In Q4 2025, revenue dynamics showed varied performance across segments. The Integrated Care segment reported a revenue increase of 5%, totaling $409.1 million. In contrast, the BetterHelp segment experienced a 7% decline, generating $233.2 million. Notably, access fees revenue decreased by 4% to $521.6 million, while other revenue surged by 24% to $120.7 million.

For the full year, Integrated Care achieved a 3% revenue growth to $1.58 billion, while BetterHelp saw a 9% decline, totaling $950.4 million.

Strategic Insights from Leadership

Chuck Divita, CEO of Teladoc Health, expressed optimism regarding the company's performance, noting that they exceeded the midpoint of their guidance for both revenue and adjusted EBITDA in the fourth quarter. He emphasized the company’s commitment to disciplined execution and innovation, stating, "We are strengthening our ability to meet the evolving needs of our clients and members to support sustainable growth over time."

Cash Flow and Capital Expenditures

Cash flow from operations for Q4 2025 stood at $87.7 million, a slight increase from $85.9 million in Q4 2024. The full year saw operational cash flow remain relatively stable at $294.4 million. Free cash flow reported for the year was $166.9 million, down 2% from 2024, indicating a resilient but cautious approach to capital management.

Financial Outlook for 2026

Looking ahead, Teladoc has set a cautious yet optimistic outlook for 2026, projecting revenue between $2.47 billion and $2.59 billion with an adjusted EBITDA forecast of $266 million to $308 million. The company expects to narrow its net loss per share to between ($1.10) and ($0.70). The anticipated growth for the Integrated Care segment is modest, whereas BetterHelp is expected to face challenges with projected revenue declines of up to 7%.

Conclusion

Teladoc Health's fourth quarter and full year results for 2025 demonstrate a company in transition, focused on innovation while navigating the complexities of the evolving healthcare landscape. As it moves into 2026, the emphasis on disciplined execution and leveraging technology will be crucial for sustaining growth and improving financial performance. The upcoming earnings conference call on February 25, 2026, will provide further insights as investors and analysts seek clarity on the company's strategic direction and operational plans for the future.

Original press release